|
|
Volumn 371, Issue 10, 2014, Pages 887-889
|
|
Chikungunya virus in the Americas - What a vectorborne pathogen can do
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANALGESIC AGENT;
ANTIPYRETIC AGENT;
GLUCOCORTICOID;
NONSTEROID ANTIINFLAMMATORY AGENT;
ADENOVIRUS INFECTION;
ALPHAVIRUS INFECTION;
ARTHRALGIA;
ARTHRITIS;
CHIKUNGUNYA;
CHIKUNGUNYA ALPHAVIRUS;
CLINICAL FEATURE;
DEATH;
DIFFERENTIAL DIAGNOSIS;
ENTEROVIRUS INFECTION;
EXPOSURE;
FLUID THERAPY;
GROUP A STREPTOCOCCAL INFECTION;
HUMAN;
INFECTION PREVENTION;
LEPTOSPIROSIS;
MALARIA;
MEASLES;
PALLIATIVE THERAPY;
PARVOVIRUS INFECTION;
PATIENT CARE;
PHYSIOTHERAPY;
RESIDENTIAL AREA;
REST;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
REVIEW;
RICKETTSIACEAE INFECTION;
RISK ASSESSMENT;
RISK REDUCTION;
RUBELLA;
SYMPTOMATOLOGY;
TRAVEL;
UNITED STATES;
VIRUS TRANSMISSION;
WESTERN HEMISPHERE;
AEDES;
ANIMAL;
ARTICLE;
DISEASE CARRIER;
DISEASE TRANSMISSION;
EPIDEMIC;
IMMUNOLOGY;
AEDES;
ALPHAVIRUS INFECTIONS;
AMERICAS;
ANIMALS;
CHIKUNGUNYA VIRUS;
DISEASE OUTBREAKS;
HUMANS;
INSECT VECTORS;
|
|
EID: 84906996606
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMp1407698 Document Type: Article |
|
Times cited : (116)
|
|
References (5)
|
